TAZ Inhibition Restores Sensitivity of Cisplatin via AKT/mTOR Signaling in Lung Adenocarcinoma

Oncology Reports - Greece
doi 10.3892/or.2017.5847
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity

Clinical Cancer Research
Cancer ResearchOncology
2004English

MicroRNA‑29c Restores Cisplatin Sensitivity in Liver Cancer Through Direct Inhibition of Sirtuin 1 Expression

Oncology Letters
Cancer ResearchOncology
2018English

Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway

Chinese Medicine
2018English

Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells

Frontiers in Oncology
Cancer ResearchOncology
2019English

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Gambogic Acid Suppresses Inflammation in Rheumatoid Arthritis Rats via PI3K/Akt/mTOR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Low Frequency Magnetic Fields Induce Autophagy-Associated Cell Death in Lung Cancer Through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway

Scientific Reports
Multidisciplinary
2017English

Aldosterone Promotes Renal Interstitial Fibrosis via the AIF‑1/AKT/mTOR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy